Portfolio Holdings Detail for ISIN IE0031442068
Stock Name / Fund iShares Core S&P 500 UCITS ETF USD (Dist)
Issuer Blackrock
Entity holding fund iShares Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300YDM1GFZR5B4U80
ETF Ticker IDUS(USD) LSE
ETF Ticker IDUS.LS(USD) CXE
ETF Ticker IUSA.AS(EUR) CXE
ETF Ticker IUSA.DE(EUR) CXE
ETF Ticker IUSA.LS(GBX) CXE
ETF Ticker IUSA.MI(EUR) CXE
ETF Ticker IUSAz(USD) CXE
ETF Ticker IUSA(EUR) ETF Plus
ETF Ticker IDUS.L(GBP) LSE

Holdings detail for EW

Stock Name	Edwards Lifesciences Corp
Ticker	EW(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US28176E1082
LEI	YA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen: Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings: Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab: Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW): Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research: Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00: Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW): J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW): Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC: Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW): Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares Core S&P 500 UCITS ETF USD (Dist) EW holdings

Date	Number of EW Shares Held	Base Market Value of EW Shares	Local Market Value of EW Shares	Change in EW Shares Held	Change in EW Base Value	Current Price per EW Share Held	Previous Price per EW Share Held
2025-09-29 (Monday)	209,105	USD 16,140,815	USD 16,140,815
2025-09-26 (Friday)	209,105	USD 15,944,256	USD 15,944,256
2025-09-25 (Thursday)	209,105	USD 15,739,333	USD 15,739,333	80	USD 133,526	USD 75.27	USD 74.66
2025-09-24 (Wednesday)	209,025	USD 15,605,807	USD 15,605,807
2025-09-18 (Thursday)	209,265	USD 15,600,706	USD 15,600,706	80	USD -130,006	USD 74.55	USD 75.2
2025-09-17 (Wednesday)	209,185	USD 15,730,712	USD 15,730,712	80	USD 29,018	USD 75.2	USD 75.09
2025-09-16 (Tuesday)	209,105	USD 15,701,694	USD 15,701,694	0	USD -200,741	USD 75.09	USD 76.05
2025-09-15 (Monday)	209,105	USD 15,902,435	USD 15,902,435
2025-09-12 (Friday)	209,105	USD 16,220,275	USD 16,220,275

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE0031442068

Show aggregate share trades of EW

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-25 BUY 80 75.270* 73.35
2025-09-18 BUY 80 74.550* 73.34
2025-09-17 BUY 80 75.200* 73.33
2025-08-19 SELL -160 78.930* 73.22 Profit of 11,714 on sale
2025-08-15 SELL -80 78.260* 73.16 Profit of 5,853 on sale
2025-08-13 SELL -400 77.680* 73.14 Profit of 29,256 on sale
2025-08-12 SELL -1,040 76.930* 73.12 Profit of 76,045 on sale
2025-08-07 SELL -1,200 77.930* 73.10 Profit of 87,714 on sale
2025-08-05 BUY 80 79.240* 73.03
2025-07-31 BUY 240 79.310* 73.00
2025-07-28 BUY 80 78.490* 72.89
2025-07-25 SELL -160 80.000* 72.85 Profit of 11,656 on sale
2025-07-24 BUY 80 75.800* 72.83
2025-07-18 BUY 80 76.490* 72.75
2025-07-14 SELL -80 78.280* 72.66 Profit of 5,813 on sale
2025-07-08 SELL -160 76.390* 72.57 Profit of 11,612 on sale
2025-07-02 BUY 480 77.020* 72.47
2025-06-24 SELL -160 75.850* 72.33 Profit of 11,572 on sale
2025-06-23 SELL -80 75.320* 72.31 Profit of 5,785 on sale
2025-06-20 SELL -480 73.830* 72.30 Profit of 34,703 on sale
2025-06-12 SELL -240 75.890* 72.25 Profit of 17,340 on sale
2025-06-11 SELL -1,214 75.470* 72.23 Profit of 87,685 on sale
2025-06-06 BUY 81 77.520* 72.14
2025-06-02 SELL -243 78.100* 71.99 Profit of 17,494 on sale
2025-05-29 SELL -81 77.730* 71.91 Profit of 5,825 on sale
2025-05-27 BUY 81 76.220* 71.85
2025-05-23 BUY 81 74.990* 71.80
2025-05-21 SELL -243 76.100* 71.75 Profit of 17,436 on sale
2025-05-15 BUY 324 76.880* 71.58
2025-05-14 SELL -486 76.750* 71.54 Profit of 34,770 on sale
2025-05-13 SELL -972 75.500* 71.51 Profit of 69,512 on sale
2025-05-07 SELL -243 75.040* 71.42 Profit of 17,356 on sale
2025-05-02 SELL -81 75.650* 71.33 Profit of 5,778 on sale
2025-04-29 SELL -243 76.280* 71.23 Profit of 17,309 on sale
2025-04-24 BUY 81 75.130* 71.13
2025-04-22 BUY 324 70.600* 71.14
2025-04-16 BUY 81 71.200* 71.14
2025-04-15 BUY 81 70.760* 71.15
2025-04-11 BUY 162 69.400* 71.17
2025-04-09 BUY 405 69.900* 71.21
2025-04-08 BUY 1,215 67.070* 71.25
2025-04-07 SELL -567 69.000* 71.27 Profit of 40,410 on sale
2025-04-04 SELL -1,215 69.360* 71.29 Profit of 86,614 on sale
2025-04-02 SELL -243 72.050* 71.28 Profit of 17,321 on sale
2025-04-01 SELL -81 71.870* 71.27 Profit of 5,773 on sale
2025-03-31 SELL -162 72.480* 71.26 Profit of 11,545 on sale
2025-03-28 BUY 162 70.910* 71.27
2025-03-25 BUY 243 71.240* 71.27
2025-03-24 BUY 324 71.350* 71.27
2025-03-21 SELL -162 70.460* 71.28 Profit of 11,547 on sale
2025-03-20 BUY 162 70.950* 71.28
2025-03-19 BUY 324 70.900* 71.28
2025-03-17 SELL -243 70.630* 71.30 Profit of 17,326 on sale
2025-03-14 SELL -162 69.290* 71.32 Profit of 11,554 on sale
2025-03-13 SELL -480 67.950* 71.36 Profit of 34,252 on sale
2025-03-11 SELL -567 68.390* 71.42 Profit of 40,496 on sale
2025-03-10 SELL -324 68.530* 71.45 Profit of 23,151 on sale
2025-03-06 SELL -324 71.800* 71.46 Profit of 23,153 on sale
2025-03-05 SELL -486 72.850* 71.45 Profit of 34,723 on sale
2025-03-04 SELL -648 71.380* 71.45 Profit of 46,297 on sale
2025-02-28 SELL -405 71.620* 71.44 Profit of 28,935 on sale
2025-02-26 BUY 162 71.960* 71.44
2025-02-24 BUY 162 72.760* 71.42
2025-02-21 BUY 81 73.300* 71.40
2025-02-20 SELL -243 74.710* 71.36 Profit of 17,340 on sale
2025-02-14 SELL -81 76.190* 71.13 Profit of 5,761 on sale
2025-02-13 SELL -1,053 76.000* 71.06 Profit of 74,827 on sale
2025-02-12 SELL -81 75.820* 71.00 Profit of 5,751 on sale
2025-02-06 SELL -324 70.990* 71.01 Profit of 23,006 on sale
2025-02-05 BUY 81 72.100* 70.99
2025-02-04 BUY 567 71.330* 70.98
2025-01-29 SELL -567 71.130* 70.92 Profit of 40,210 on sale
2025-01-28 BUY 162 72.560* 70.89
2025-01-24 BUY 81 68.990* 70.95
2025-01-22 BUY 162 69.040* 71.02
2025-01-16 BUY 162 69.860* 71.10
2025-01-15 BUY 81 70.280* 71.12
2025-01-10 BUY 162 73.420* 71.08
2025-01-02 BUY 243 72.590* 70.91
2024-12-31 BUY 162 74.030* 70.85
2024-12-27 BUY 81 75.650* 70.66
2024-12-20 SELL -5,033 74.810* 70.20 Profit of 353,325 on sale
2024-12-19 BUY 82 73.930* 70.11
2024-12-18 SELL -82 72.810* 70.03 Profit of 5,743 on sale
2024-12-17 BUY 164 74.120* 69.92
2024-12-13 BUY 82 73.320* 69.71
2024-12-10 BUY 82 73.390* 69.48
2024-12-06 SELL -164 71.530* 69.37 Profit of 11,376 on sale
2024-12-05 BUY 82 72.430* 69.26
2024-12-04 SELL -656 74.200* 69.09 Profit of 45,326 on sale
2024-12-03 BUY 246 70.200* 69.05
2024-12-02 BUY 410 70.530* 69.00
2024-11-27 BUY 82 72.070* 68.65
2024-11-26 BUY 574 71.550* 68.52
2024-11-21 BUY 249 70.380* 68.19
2024-11-20 BUY 164 69.540* 68.12
2024-11-19 BUY 82 70.200* 68.00
2024-11-18 BUY 164 69.890* 67.89
2024-11-12 BUY 328 65.810* 68.02
2024-11-11 BUY 164 66.700* 68.11
2024-11-08 BUY 656 66.230* 68.25
2024-11-07 BUY 574 65.840* 68.43
2024-11-06 BUY 656 65.750* 68.66
2024-11-05 SELL -164 66.690* 68.83 Profit of 11,289 on sale
2024-11-04 BUY 164 66.470* 69.07
2024-11-01 BUY 574 67.540* 69.24
2024-10-28 BUY 410 68.520* 69.93
2024-10-25 BUY 902 69.380* 70.06
2024-10-23 SELL -82 70.610* 69.65 Profit of 5,711 on sale
2024-10-21 BUY 82 70.050* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-25	BUY	80	75.270*	73.35
2025-09-18	BUY	80	74.550*	73.34
2025-09-17	BUY	80	75.200*	73.33
2025-08-19	SELL	-160	78.930*	73.22 Profit of 11,714 on sale
2025-08-15	SELL	-80	78.260*	73.16 Profit of 5,853 on sale
2025-08-13	SELL	-400	77.680*	73.14 Profit of 29,256 on sale
2025-08-12	SELL	-1,040	76.930*	73.12 Profit of 76,045 on sale
2025-08-07	SELL	-1,200	77.930*	73.10 Profit of 87,714 on sale
2025-08-05	BUY	80	79.240*	73.03
2025-07-31	BUY	240	79.310*	73.00
2025-07-28	BUY	80	78.490*	72.89
2025-07-25	SELL	-160	80.000*	72.85 Profit of 11,656 on sale
2025-07-24	BUY	80	75.800*	72.83
2025-07-18	BUY	80	76.490*	72.75
2025-07-14	SELL	-80	78.280*	72.66 Profit of 5,813 on sale
2025-07-08	SELL	-160	76.390*	72.57 Profit of 11,612 on sale
2025-07-02	BUY	480	77.020*	72.47
2025-06-24	SELL	-160	75.850*	72.33 Profit of 11,572 on sale
2025-06-23	SELL	-80	75.320*	72.31 Profit of 5,785 on sale
2025-06-20	SELL	-480	73.830*	72.30 Profit of 34,703 on sale
2025-06-12	SELL	-240	75.890*	72.25 Profit of 17,340 on sale
2025-06-11	SELL	-1,214	75.470*	72.23 Profit of 87,685 on sale
2025-06-06	BUY	81	77.520*	72.14
2025-06-02	SELL	-243	78.100*	71.99 Profit of 17,494 on sale
2025-05-29	SELL	-81	77.730*	71.91 Profit of 5,825 on sale
2025-05-27	BUY	81	76.220*	71.85
2025-05-23	BUY	81	74.990*	71.80
2025-05-21	SELL	-243	76.100*	71.75 Profit of 17,436 on sale
2025-05-15	BUY	324	76.880*	71.58
2025-05-14	SELL	-486	76.750*	71.54 Profit of 34,770 on sale
2025-05-13	SELL	-972	75.500*	71.51 Profit of 69,512 on sale
2025-05-07	SELL	-243	75.040*	71.42 Profit of 17,356 on sale
2025-05-02	SELL	-81	75.650*	71.33 Profit of 5,778 on sale
2025-04-29	SELL	-243	76.280*	71.23 Profit of 17,309 on sale
2025-04-24	BUY	81	75.130*	71.13
2025-04-22	BUY	324	70.600*	71.14
2025-04-16	BUY	81	71.200*	71.14
2025-04-15	BUY	81	70.760*	71.15
2025-04-11	BUY	162	69.400*	71.17
2025-04-09	BUY	405	69.900*	71.21
2025-04-08	BUY	1,215	67.070*	71.25
2025-04-07	SELL	-567	69.000*	71.27 Profit of 40,410 on sale
2025-04-04	SELL	-1,215	69.360*	71.29 Profit of 86,614 on sale
2025-04-02	SELL	-243	72.050*	71.28 Profit of 17,321 on sale
2025-04-01	SELL	-81	71.870*	71.27 Profit of 5,773 on sale
2025-03-31	SELL	-162	72.480*	71.26 Profit of 11,545 on sale
2025-03-28	BUY	162	70.910*	71.27
2025-03-25	BUY	243	71.240*	71.27
2025-03-24	BUY	324	71.350*	71.27
2025-03-21	SELL	-162	70.460*	71.28 Profit of 11,547 on sale
2025-03-20	BUY	162	70.950*	71.28
2025-03-19	BUY	324	70.900*	71.28
2025-03-17	SELL	-243	70.630*	71.30 Profit of 17,326 on sale
2025-03-14	SELL	-162	69.290*	71.32 Profit of 11,554 on sale
2025-03-13	SELL	-480	67.950*	71.36 Profit of 34,252 on sale
2025-03-11	SELL	-567	68.390*	71.42 Profit of 40,496 on sale
2025-03-10	SELL	-324	68.530*	71.45 Profit of 23,151 on sale
2025-03-06	SELL	-324	71.800*	71.46 Profit of 23,153 on sale
2025-03-05	SELL	-486	72.850*	71.45 Profit of 34,723 on sale
2025-03-04	SELL	-648	71.380*	71.45 Profit of 46,297 on sale
2025-02-28	SELL	-405	71.620*	71.44 Profit of 28,935 on sale
2025-02-26	BUY	162	71.960*	71.44
2025-02-24	BUY	162	72.760*	71.42
2025-02-21	BUY	81	73.300*	71.40
2025-02-20	SELL	-243	74.710*	71.36 Profit of 17,340 on sale
2025-02-14	SELL	-81	76.190*	71.13 Profit of 5,761 on sale
2025-02-13	SELL	-1,053	76.000*	71.06 Profit of 74,827 on sale
2025-02-12	SELL	-81	75.820*	71.00 Profit of 5,751 on sale
2025-02-06	SELL	-324	70.990*	71.01 Profit of 23,006 on sale
2025-02-05	BUY	81	72.100*	70.99
2025-02-04	BUY	567	71.330*	70.98
2025-01-29	SELL	-567	71.130*	70.92 Profit of 40,210 on sale
2025-01-28	BUY	162	72.560*	70.89
2025-01-24	BUY	81	68.990*	70.95
2025-01-22	BUY	162	69.040*	71.02
2025-01-16	BUY	162	69.860*	71.10
2025-01-15	BUY	81	70.280*	71.12
2025-01-10	BUY	162	73.420*	71.08
2025-01-02	BUY	243	72.590*	70.91
2024-12-31	BUY	162	74.030*	70.85
2024-12-27	BUY	81	75.650*	70.66
2024-12-20	SELL	-5,033	74.810*	70.20 Profit of 353,325 on sale
2024-12-19	BUY	82	73.930*	70.11
2024-12-18	SELL	-82	72.810*	70.03 Profit of 5,743 on sale
2024-12-17	BUY	164	74.120*	69.92
2024-12-13	BUY	82	73.320*	69.71
2024-12-10	BUY	82	73.390*	69.48
2024-12-06	SELL	-164	71.530*	69.37 Profit of 11,376 on sale
2024-12-05	BUY	82	72.430*	69.26
2024-12-04	SELL	-656	74.200*	69.09 Profit of 45,326 on sale
2024-12-03	BUY	246	70.200*	69.05
2024-12-02	BUY	410	70.530*	69.00
2024-11-27	BUY	82	72.070*	68.65
2024-11-26	BUY	574	71.550*	68.52
2024-11-21	BUY	249	70.380*	68.19
2024-11-20	BUY	164	69.540*	68.12
2024-11-19	BUY	82	70.200*	68.00
2024-11-18	BUY	164	69.890*	67.89
2024-11-12	BUY	328	65.810*	68.02
2024-11-11	BUY	164	66.700*	68.11
2024-11-08	BUY	656	66.230*	68.25
2024-11-07	BUY	574	65.840*	68.43
2024-11-06	BUY	656	65.750*	68.66
2024-11-05	SELL	-164	66.690*	68.83 Profit of 11,289 on sale
2024-11-04	BUY	164	66.470*	69.07
2024-11-01	BUY	574	67.540*	69.24
2024-10-28	BUY	410	68.520*	69.93
2024-10-25	BUY	902	69.380*	70.06
2024-10-23	SELL	-82	70.610*	69.65 Profit of 5,711 on sale
2024-10-21	BUY	82	70.050*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	406,402	0	1,881,727	21.6%
2025-09-18	684,520	1,177	3,487,981	19.6%
2025-09-17	484,322	210	1,603,065	30.2%
2025-09-16	811,953	856	2,055,937	39.5%
2025-09-15	611,012	104	1,391,882	43.9%
2025-09-12	982,928	1,100	2,234,227	44.0%
2025-09-11	514,234	828	1,919,009	26.8%
2025-09-10	669,705	149	1,567,941	42.7%
2025-09-09	441,493	0	925,375	47.7%
2025-09-08	632,587	672	1,251,939	50.5%
2025-09-05	334,037	300	934,006	35.8%
2025-09-04	380,318	0	871,931	43.6%
2025-09-03	701,943	459	1,170,966	59.9%
2025-09-02	397,396	53	1,208,872	32.9%
2025-08-29	397,628	800	844,318	47.1%
2025-08-28	604,087	4	1,056,653	57.2%
2025-08-27	493,608	822	875,886	56.4%
2025-08-26	480,268	0	868,213	55.3%
2025-08-25	796,556	0	1,181,258	67.4%
2025-08-22	552,739	1	1,011,678	54.6%
2025-08-21	873,044	798	1,597,742	54.6%
2025-08-20	847,847	38,699	1,560,105	54.3%
2025-08-19	613,349	33	1,256,577	48.8%
2025-08-18	668,719	439	1,642,759	40.7%
2025-08-15	369,455	513	826,723	44.7%
2025-08-14	514,202	6,112	864,593	59.5%
2025-08-13	567,857	299	1,347,264	42.1%
2025-08-12	547,773	12,316	1,428,277	38.4%
2025-08-11	487,823	0	1,152,630	42.3%
2025-08-08	661,697	20	1,224,458	54.0%
2025-08-07	669,931	982	1,297,469	51.6%
2025-08-06	880,028	413	1,551,659	56.7%
2025-08-05	661,933	8	1,592,649	41.6%
2025-08-04	572,165	268	1,310,044	43.7%
2025-08-01	678,028	5,600	1,308,863	51.8%
2025-07-31	831,401	249	1,817,975	45.7%
2025-07-30	1,305,016	693	2,481,808	52.6%
2025-07-29	1,129,154	58	2,399,223	47.1%
2025-07-28	684,101	2,111	2,276,892	30.0%
2025-07-25	1,669,752	920	6,616,259	25.2%
2025-07-24	455,593	0	2,607,898	17.5%
2025-07-23	444,645	0	1,978,110	22.5%
2025-07-22	447,883	511	2,702,925	16.6%
2025-07-21	568,293	27	1,249,727	45.5%
2025-07-18	590,448	59	2,118,402	27.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Core S&P 500 UCITS ETF USD (Dist)
Issuer	Blackrock
Entity holding fund	iShares Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300YDM1GFZR5B4U80
ETF Ticker	IDUS(USD) LSE
ETF Ticker	IDUS.LS(USD) CXE
ETF Ticker	IUSA.AS(EUR) CXE
ETF Ticker	IUSA.DE(EUR) CXE
ETF Ticker	IUSA.LS(GBX) CXE
ETF Ticker	IUSA.MI(EUR) CXE
ETF Ticker	IUSAz(USD) CXE
ETF Ticker	IUSA(EUR) ETF Plus
ETF Ticker	IDUS.L(GBP) LSE